Vicarious Surgical Inc.

RBOT

US92561V1098

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
0.263 ^USD	-3.63%		-5.73%	-28.28%

Mar. 05	Piper Sandler Adjusts Price Target on Vicarious Surgical to $1 From $1.50, Keeps Neutral Rating	MT
Mar. 04	Vicarious Surgical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Vicarious Surgical Inc.(NYSE:RBOT) added to S&P TMI Index

December 20, 2021 at 12:00 am EST

Latest news about Vicarious Surgical Inc.

Piper Sandler Adjusts Price Target on Vicarious Surgical to $1 From $1.50, Keeps Neutral Rating	Mar. 05	MT
Vicarious Surgical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 04	CI
Transcript : Vicarious Surgical Inc., Q4 2023 Earnings Call, Mar 04, 2024	Mar. 04
Vicarious Surgical Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 04	CI
Vicarious Surgical Inc. Announces Intention of David Styka to Resign as Executive Chairman and Member of the Board	Mar. 04	CI
North American Morning Briefing : Stock Futures -2-	Mar. 04	DJ
North American Morning Briefing : Stock Futures -2-	Feb. 12	DJ
Vicarious Surgical Inc. Announces Management Changes	Jan. 29	CI
Morgan Stanley Initiates Vicarious Surgical With Equalweight Rating, Price Target is $0.60	Dec. 04	MT
North American Morning Briefing : Stocks Seen -2-	Nov. 15	DJ
BTIG Research Downgrades Vicarious Surgical to Neutral From Buy	Nov. 14	MT
Transcript : Vicarious Surgical Inc., Q3 2023 Earnings Call, Nov 13, 2023	Nov. 13
Vicarious Surgical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Certain Restricted Stock Units of Vicarious Surgical Inc. are subject to a Lock-Up Agreement Ending on 1-NOV-2023.	Oct. 31	CI
Certain Stock Options of Vicarious Surgical Inc. are subject to a Lock-Up Agreement Ending on 1-NOV-2023.	Oct. 31	CI
Certain Warrants of Vicarious Surgical Inc. are subject to a Lock-Up Agreement Ending on 1-NOV-2023.	Oct. 31	CI
Certain Class A Common Stock of Vicarious Surgical Inc. are subject to a Lock-Up Agreement Ending on 1-NOV-2023.	Oct. 31	CI
Top Premarket Decliners	23-08-03	MT
Transcript : Vicarious Surgical Inc., Q2 2023 Earnings Call, Jul 27, 2023	23-07-27
Vicarious Surgical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-27	CI
Vicarious Surgical Inc.(NYSE:RBOT) added to Russell Small Cap Comp Value Index	23-06-23	CI
Vicarious Surgical Inc.(NYSE:RBOT) added to Russell Microcap Value Index	23-06-23	CI
Vicarious Surgical Inc.(NYSE:RBOT) dropped from Russell 2000 Growth-Defensive Index	23-06-23	CI
Vicarious Surgical Inc.(NYSE:RBOT) dropped from Russell 2000 Defensive Index	23-06-23	CI
Vicarious Surgical Inc.(NYSE:RBOT) added to Russell 3000E Value Index	23-06-23	CI

Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.2 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-28 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.2729 USD

Average target price

1.033 USD

Spread / Average Target

+278.65%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
VICARIOUS SURGICAL INC.	-28.28%	48.04M
THERMO FISHER SCIENTIFIC	+7.71%	220B
DANAHER CORPORATION	+6.25%	185B
INTUITIVE SURGICAL, INC.	+10.60%	133B
BOSTON SCIENTIFIC CORPORATION	+26.73%	107B
SIEMENS HEALTHINEERS AG	-0.57%	62.91B
EDWARDS LIFESCIENCES CORPORATION	+15.42%	53.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.89%	47.71B
AGILENT TECHNOLOGIES, INC.	-1.91%	40.29B
GE HEALTHCARE TECHNOLOGIES INC.	+11.16%	39.57B

Other Advanced Medical Equipment & Technology